Catheter ablation of ventricular fibrillation triggers and electrical storm

Europace

Volumn 14, Issue 12, 2012, Pages 1687-1695

  Tan, Vern Hsen ^a   Yap, Jonathan ^a   Hsu, Li Fern ^a,b   Liew, Reginald ^a,c  

^a DEPARTMENT OF CARDIOLOGY   (Singapore)

^b Novena Heart Centre   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Catheter ablation; Electrical storm; Electrophysiological study; Purkinje potentials; Ventricular fibrillation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; RYANODINE RECEPTOR 2;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; BRUGADA SYNDROME; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CATHETER ABLATION; CHRONIC DISEASE; CLINICAL EVALUATION; CONGESTIVE CARDIOMYOPATHY; FOLLOW UP; HEART AMYLOIDOSIS; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART MUSCLE REVASCULARIZATION; HEART PACING; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HIGH RISK PATIENT; HUMAN; IDIOPATHIC DISEASE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; LONG QT SYNDROME; MYOCARDITIS; OUT OF HOSPITAL CARDIAC ARREST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PURKINJE FIBER; QT INTERVAL; REVIEW; SARCOPLASMIC RETICULUM; SURGICAL PATIENT; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

CATHETER ABLATION; HEART CONDUCTION SYSTEM; HUMANS; MODELS, CARDIOVASCULAR; VENTRICULAR FIBRILLATION;

EID: 84870191729     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus050     Document Type: Review

References (64)

1. Zipes DP, Wellens HJ. Sudden cardiac death. Circulation 1998; 98:2334-51. (Pubitemid 28533855)
2. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996; 335:1933-40. (Pubitemid 26428217)
3. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-83.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352:225-37. (Pubitemid 40110811)
5. Doppalapudi H, Yamada T, mcelderry HT, Plumb VJ, Epstein AE, Kay GN. Ventricular tachycardia originating from the posterior papillary muscle in the left ventricle: a distinct clinical syndrome. Circ Arrhythm Electrophysiol 2008; 1:23-9.
6. Villacastin J, Almendral J, Arenal A, Albertos J, Ormaetxe J, Peinado R et al. Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators. Circulation 1996; 93:753-62. (Pubitemid 26052462)
7. Huang DT, Traub D. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review. Prog Cardiovasc Dis 2008; 51:229-36.
8. Cerrone M, Priori SG. Genetics of sudden death: focus on inherited channelopathies. Eur Heart J 2011; 32:2109-18.
9. Sovari AA, Iravanian S, Dolmatova E, Jiao Z, Liu H, Zandieh S et al. Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac death. J Am Coll Cardiol 2011; 58:2332-9.
10. Morrow JP, Katchman A, Son NH, Trent CM, Khan R, Shiomi T et al. Mice with cardiac overexpression of peroxisome proliferator-activated receptor gamma have impaired repolarization and spontaneous fatal ventricular arrhythmias. Circulation 2011; 124:2812-21.
11. Tsuji Y, Hojo M, Voigt N, El-Armouche A, Inden Y, Murohara T et al. Ca(2+)-related signaling and protein phosphorylation abnormalities play central roles in a new experimental model of electrical storm. Circulation 2011; 123:2192-203.
12. Janse MJ. Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 2004; 61:208-17. (Pubitemid 38091761)
13. Mccauley MD, Wehrens XH. Targeting ryanodine receptors for anti-arrhythmic therapy. Acta Pharmacol Sin 2011; 32:749-57.
14. Del Monte F, Lebeche D, Guerrero JL, Tsuji T, Doye AA, Gwathmey JK et al. Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling. Proc Natl Acad Sci U S A 2004; 101:5622-7. (Pubitemid 38481206)
15. Prunier F, Kawase Y, Gianni D, Scapin C, Danik SB, Ellinor PT et al. Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ atpase pump overex-pression in a porcine model of ischemia reperfusion. Circulation 2008; 118:614-24.
16. Tabereaux PB, Walcott GP, Rogers JM, Kim J, Dosdall DJ, Robertson PG et al. Activation patterns of Purkinje fibers during long-duration ventricular fibrillation in an isolated canine heart model. Circulation 2007; 116:1113-9. (Pubitemid 47360213)
17. Dosdall DJ, Tabereaux PB, Kim JJ, Walcott GP, Rogers JM, Killingsworth CR et al. Chemical ablation of the Purkinje system causes early termination and activation rate slowing of long-duration ventricular fibrillation in dogs. Am J Physiol Heart Circ Physiol 2008;295:H883-9.
18. Wu TJ, Ong JJ, Hwang C, Lee JJ, Fishbein MC, Czer L et al. Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. J Am Coll Cardiol 1998;32: 187-96. (Pubitemid 28351061)
19. Mcanulty RJ. Fibroblasts and myofibroblasts: their source, function and role in disease. Int J Biochem Cell Biol 2007;39:666-71.
20. Pandit SV, Zlochiver S, Filgueiras-Rama D, Mironov S, Yamazaki M, Ennis SR et al. Targeting atrioventricular differences in ion channel properties for terminating acute atrial fibrillation in pigs. Cardiovasc Res 2011;89:843-51.
21. Cao JM, Chen LS, kenknight BH, Ohara T, Lee MH, Tsai J et al. Nerve sprouting and sudden cardiac death. Circ Res 2000;86:816-21. (Pubitemid 30217832)
22. Cao JM, Fishbein MC, Han JB, Lai WW, Lai AC, Wu TJ et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000; 101:1960-9. (Pubitemid 30225278)
23. Ellison KE, Hafley GE, Hickey K, Kellen J, Coromilas J, Stein KM et al. Effect of beta-blocking therapy on outcome in the Multicenter unsustained Tachycardia Trial (MUSTT). Circulation 2002;106:2694-9. (Pubitemid 35364924)
24. Siu CW, Pong V, Jim MH, Yue WS, Ho HH, Li SW et al. Beta-blocker in post-myocardial infarct survivors with preserved left ventricular systolic function. Pacing Clin Electrophysiol 2010;33:675-80.
25. Matsue Y, Suzuki M, Nagahori W, Ohno M, Matsumura A, Hashimoto Y. Beta-blocker prevents sudden cardiac death in patients with hemodialysis. Int J Cardiol; online publish ahead of print 11 October 2011, doi:10.1016/j.ijcard. 2011.09.037.
26. Goldenberg I, Bradley J, Moss A, mcnitt S, Polonsky S, Robinson JL et al. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient management. J Cardiovasc Electrophysiol 2010;21:893-901.
27. Xie X, Visweswaran R, Guzman PA, Smith RM, Osborn JW, Tolkacheva EG. The effect of cardiac sympathetic denervation through bilateral stellate ganglionectomy on electrical properties of the heart. Am J Physiol Heart Circ Physiol 2011; 301:H192-9.
28. Chen PS, Wu TJ, Ting CT, Karagueuzian HS, Garfinkel A, Lin SF et al. A tale of two fibrillations. Circulation 2003;108:2298-303. (Pubitemid 37413532)
29. Jalife J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu Rev Physiol 2000;62:25-50. (Pubitemid 30618255)
30. Li L, Jin Q, Huang J, Cheng KA, Ideker RE. Intramural foci during long duration fibrillation in the pig ventricle. Circ Res 2008;102:1256-64.
31. Valderrabano M, Lee MH, Ohara T, Lai AC, Fishbein MC, Lin SF et al. Dynamics of intramural and transmural reentry during ventricular fibrillation in isolated swine ventricles. Circ Res 2001;88:839-48. (Pubitemid 32429981)
32. Kim YH, Xie F, Yashima M, Wu TJ, Valderrabano M, Lee MH et al. Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle. Circulation 1999;100:1450-9. (Pubitemid 29451707)
33. Schmidt A, Azevedo CF, Cheng A, Gupta SN, Bluemke DA, Foo TK et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007;115:2006-14. (Pubitemid 46625951)
34. Chow AW, Segal OR, Davies DW, Peters NS. Mechanism of pacing-induced ventricular fibrillation in the infarcted human heart. Circulation 2004;110:1725-30. (Pubitemid 39299212)
35. Coronel R, Casini S, Koopmann TT, Wilms-Schopman FJ, Verkerk AO, de Groot JR et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, his-topathologic, and computational study. Circulation 2005;112:2769-77. (Pubitemid 41641670)
36. Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Jirasirirojanakorn K et al. Prevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardium. Circulation 2011;123:1270-9.
37. Kakishita M, Kurita T, Matsuo K, Taguchi A, Suyama K, Shimizu W et al. Mode of onset of ventricular fibrillation in patients with Brugada syndrome detected by implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000;36:1646-53.
38. Haissaguerre M, Shah DC, Jais P, Shoda M, Kautzner J, Arentz T et al. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet 2002;359:677-8. (Pubitemid 34203772)
39. Haissaguerre M, Shoda M, Jais P, Nogami A, Shah DC, Kautzner J et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation 2002;106:962-7. (Pubitemid 34925331)
40. Haissaguerre M, Derval N, Sacher F, Jesel L, Deisenhofer I, de Roy L et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 2008;358: 2016-23. (Pubitemid 351681636)
41. Knecht S, Sacher F, Wright M, Hocini M, Nogami A, Arentz T et al. Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. J Am Coll Cardiol 2009;54:522-8.
42. Schulze-Bahr E. Susceptibility genes & modifiers for cardiac arrhythmias. Prog Biophys Mol Biol 2008;98:289-300.
43. Madias C, Fitzgibbons TP, Alsheikh-Ali AA, Bouchard JL, Kalsmith B, Garlitski AC et al. Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes. Heart Rhythm 2011;8:555-61.
44. Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera JA et al. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation 2003;108:925-8. (Pubitemid 37048219)
45. Srivathsan K, Gami AS, Ackerman MJ, Asirvatham SJ. Treatment of ventricular fibrillation in a patient with prior diagnosis of long QT syndrome: importance of precise electrophysiologic diagnosis to successfully ablate the trigger. Heart Rhythm 2007;4:1090-3. (Pubitemid 47163731)
46. Darmon JP, Bettouche S, Deswardt P, Tiger F, Ricard P, Bernasconi F et al. Radio-frequency ablation of ventricular fibrillation and multiple right and left atrial tachycardia in a patient with Brugada syndrome. J Interv Card Electrophysiol 2004;11:205-9. (Pubitemid 40941241)
47. Nakagawa E, Takagi M, Tatsumi H, Yoshiyama M. Successful radiofrequency catheter ablation for electrical storm of ventricular fibrillation in a patient with Brugada syndrome. Circ J 2008;72:1025-9. (Pubitemid 351879930)
48. Papavassiliu T, Veltmann C, Doesch C, Haghi D, Germans T, Schoenberg SO et al. Spontaneous type 1 electrocardiographic pattern is associated with cardiovascular magnetic resonance imaging changes in Brugada syndrome. Heart Rhythm 2010; 7:1790-6.
49. Bode K, Hindricks G, Piorkowski C, Sommer P, Janousek J, Dagres N et al. Ablation of polymorphic ventricular tachycardias in patients with structural heart disease. Pacing Clin Electrophysiol 2008;31:1585-91.
50. Kozeluhova M, Peichl P, Cihak R, Wichterle D, Vancura V, Bytesnik J et al. Catheter ablation of electrical storm in patients with structural heart disease. Europace 2011;13:109-13.
51. Bansch D, Oyang F, Antz M, Arentz T, Weber R, Val-Mejias JE et al. Successful catheter ablation of electrical storm after myocardial infarction. Circulation 2003; 108:3011-6. (Pubitemid 37553571)
52. Enjoji Y, Mizobuchi M, Muranishi H, Miyamoto C, Utsunomiya M, Funatsu A et al. Catheter ablation of fatal ventricular tachyarrhythmias storm in acute coronary syndrome-role of Purkinje fiber network. J Interv Card Electrophysiol 2009;26: 207-15.
53. Marrouche NF, Verma A, Wazni O, Schweikert R, Martin DO, Saliba W et al. Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy. J Am Coll Cardiol 2004;43:1715-20. (Pubitemid 38561357)
54. Kirubakaran S, Gill J, Rinaldi CA. Successful catheter ablation of focal ventricular fibrillation in a patient with nonischemic dilated cardiomyopathy. Pacing Clin Electrophysiol 2011;34:e38-42.
55. Sinha AM, Schmidt M, Marschang H, Gutleben K, Ritscher G, Brachmann J et al. Role of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathy. Pacing Clin Electrophysiol 2009;32:286-90.
56. Mlcochova H, Saliba WI, Burkhardt DJ, Rodriguez RE, Cummings JE, Lakkireddy D et al. Catheter ablation of ventricular fibrillation storm in patients with infiltrative amyloidosis of the heart. J Cardiovasc Electrophysiol 2006;17:426-30.
57. Sanders P, Hsu LF, Hocini M, Jais P, Takahashi Y, Rotter M et al. Mapping and ablation of ventricular fibrillation. Minerva Cardioangiol 2004;52:171-81. (Pubitemid 39044703)
58. Li YG, Gronefeld G, Israel C, Hohnloser SH. Catheter ablation of frequently recurring ventricular fibrillation in a patient after aortic valve repair. J Cardiovasc Electrophysiol 2004;15:90-3. (Pubitemid 38147227)
59. Peichl P, Cihak R, Kozeluhova M, Wichterle D, Vancura V, Kautzner J. Catheter ablation of arrhythmic storm triggered by monomorphic ectopic beats in patients with coronary artery disease. J Interv Card Electrophysiol 2010;27:51-9.
60. Zheng Y, Wei D, Fang Z, Zhu X. Influences of sites and protocols on inducing ventricular fibrillation: a computer simulation study. Conf Proc IEEE Eng Med Biol Soc 2010;2010:2005-8.
61. Grzeda KR, Anumonwo JM, O'Connell R, Jalife J. A single-cell model of phase-driven control of ventricular fibrillation frequency. Biophys J 2009;96: 2961-76.
62. Hou L, Deo M, Furspan P, Pandit SV, Mironov S, Auerbach DS et al. A major role for HERG in determining frequency of reentry in neonatal rat ventricular myocyte monolayer. Circ Res 2010;107:1503-11.
63. Morita N, Sovari AA, Xie Y, Fishbein MC, Mandel WJ, Garfinkel A et al. Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress. Am J Physiol Heart Circ Physiol 2009;297:H1594-605.
64. Morita N, Lee JH, Xie Y, Sovari A, Qu Z, Weiss JN et al. Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine. J Am Coll Cardiol 2011;57:366-75.